SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 40 filers reported holding SINOVAC BIOTECH LTD in Q4 2013. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $121,000 | -5.5% | 24,460 | 0.0% | 0.00% | – |
| Q4 2014 | $128,000 | -0.8% | 24,460 | -9.0% | 0.00% | – |
| Q3 2014 | $129,000 | -24.6% | 26,893 | -11.2% | 0.00% | – |
| Q2 2014 | $171,000 | -1.7% | 30,271 | +25.0% | 0.00% | – |
| Q1 2014 | $174,000 | +3.0% | 24,208 | -12.4% | 0.00% | – |
| Q4 2013 | $169,000 | +9.0% | 27,623 | +6.2% | 0.00% | – |
| Q3 2013 | $155,000 | +7.6% | 26,002 | -28.8% | 0.00% | – |
| Q2 2013 | $144,000 | – | 36,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,000,000 | 7.22% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.18% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.82% |
| Financial Gravity Asset Management, Inc. | 988 | $3,197,686 | 0.04% |
| Yorktown Management & Research Co Inc | 149,786 | $4,494 | 0.01% |
| Renaissance Technologies | 2,375,841 | $1,537 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,661 | $10,747 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $2,666 | 0.00% |